-
1
-
-
0033600282
-
Predicting outcome in neuroblastoma
-
10.1056/NEJM199906243402510. 10379025
-
Predicting outcome in neuroblastoma. RP Castleberry, N Engl J Med 1999 340 1992 1993 10.1056/NEJM199906243402510 10379025
-
(1999)
N Engl J Med
, vol.340
, pp. 1992-1993
-
-
Castleberry, R.P.1
-
2
-
-
0033119675
-
Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting
-
10.1016/S0959-8049(98)00395-5. 10492635
-
Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting. V Castel P Garcia-Miguel A Canete C Melero A Navajas JI Ruiz-Jimenez S Navarro MD Badal, Eur J Cancer 1999 35 606 611 10.1016/S0959-8049(98)00395-5 10492635
-
(1999)
Eur J Cancer
, vol.35
, pp. 606-611
-
-
Castel, V.1
Garcia-Miguel, P.2
Canete, A.3
Melero, C.4
Navajas, A.5
Ruiz-Jimenez, J.I.6
Navarro, S.7
Badal, M.D.8
-
3
-
-
0031409775
-
The International Neuroblastoma Risk Groups (INRG): A preliminary report
-
10.1016/S0959-8049(97)00202-5. 9516864
-
The International Neuroblastoma Risk Groups (INRG): a preliminary report. RP Castleberry J Pritchard P Ambros F Berthold GM Brodeur V Castel SL Cohn B De Bernardi C Dicks-Mireaux D Frappaz GM Haase M Haber DR Jones VV Joshi M Kaneko JT Kemshead P Kogner REJ Lee KK Matthay JM Michon R Monclair BR Roald RC Seeger PJ Shaw H Shimada JJ Shuster, Eur J Cancer 1997 33 2113 2116 10.1016/S0959-8049(97)00202-5 9516864
-
(1997)
Eur J Cancer
, vol.33
, pp. 2113-2116
-
-
Castleberry, R.P.1
Pritchard, J.2
Ambros, P.3
Berthold, F.4
Brodeur, G.M.5
Castel, V.6
Cohn, S.L.7
De Bernardi, B.8
Dicks-Mireaux, C.9
Frappaz, D.10
Haase, G.M.11
Haber, M.12
Jones, D.R.13
Joshi, V.V.14
Kaneko, M.15
Kemshead, J.T.16
Kogner, P.17
Lee, R.E.J.18
Matthay, K.K.19
Michon, J.M.20
Monclair, R.21
Roald, B.R.22
Seeger, R.C.23
Shaw, P.J.24
Shimada, H.25
Shuster, J.J.26
more..
-
4
-
-
0033565765
-
The International Neuroblastoma Pathology Classification (the Shimada system)
-
10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7. 10421273
-
The International Neuroblastoma Pathology Classification (the Shimada system). H Shimada IM Ambros LP Dehner J Hata VV Joshi B Roald DO Stram RB Gerbing JN Lukens KK Matthay RP Castleberry, Cancer 1999 86 364 372 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7 10421273
-
(1999)
Cancer
, vol.86
, pp. 364-372
-
-
Shimada, H.1
Ambros, I.M.2
Dehner, L.P.3
Hata, J.4
Joshi, V.V.5
Roald, B.6
Stram, D.O.7
Gerbing, R.B.8
Lukens, J.N.9
Matthay, K.K.10
Castleberry, R.P.11
-
5
-
-
0030861490
-
MYCN protein expression as a predictor of neuroblastoma prognosis
-
9815553
-
MYCN protein expression as a predictor of neuroblastoma prognosis. HS Chan BL Gallie G DeBoer G Haddad N Ikegaki J Dimitroulakos H Yeger V Ling, Clin Cancer Res 1997 3 1699 1706 9815553
-
(1997)
Clin Cancer Res
, vol.3
, pp. 1699-1706
-
-
Chan, H.S.1
Gallie, B.L.2
Deboer, G.3
Haddad, G.4
Ikegaki, N.5
Dimitroulakos, J.6
Yeger, H.7
Ling, V.8
-
6
-
-
0026653076
-
Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma
-
10.1016/0959-8049(92)90508-Y. 1515242
-
Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma. SJ Gordon AD Pearson MM Reid AW Craft, Eur J Cancer 1992 28A 1319 1323 10.1016/0959-8049(92)90508-Y 1515242
-
(1992)
Eur J Cancer
, vol.28
, pp. 1319-1323
-
-
Gordon, S.J.1
Pearson, A.D.2
Reid, M.M.3
Craft, A.W.4
-
7
-
-
0037118589
-
Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH
-
10.1038/sj.onc.1205445. 12032861
-
Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. ZZ Su DC Kang Y Chen O Pekarskaya W Chao DJ Volsky PB Fisher, Oncogene 2002 21 3592 3602 10.1038/sj.onc.1205445 12032861
-
(2002)
Oncogene
, vol.21
, pp. 3592-3602
-
-
Su, Z.Z.1
Kang, D.C.2
Chen, Y.3
Pekarskaya, O.4
Chao, W.5
Volsky, D.J.6
Fisher, P.B.7
-
8
-
-
20444389341
-
Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1
-
10.1016/j.gene.2005.04.006. 15927426
-
Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. DC Kang ZZ Su D Sarkar L Emdad DJ Volsky PB Fisher, Gene 2005 353 8 15 10.1016/j.gene.2005.04.006 15927426
-
(2005)
Gene
, vol.353
, pp. 8-15
-
-
Kang, D.C.1
Su, Z.Z.2
Sarkar, D.3
Emdad, L.4
Volsky, D.J.5
Fisher, P.B.6
-
9
-
-
33751257780
-
Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc
-
17088530. 10.1073/pnas.0608386103
-
Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. SG Lee ZZ Su L Emdad D Sarkar PB Fisher, Proc Natl Acad Sci USA 2006 103 17390 17395 17088530 10.1073/pnas.0608386103
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 17390-17395
-
-
Lee, S.G.1
Su, Z.Z.2
Emdad, L.3
Sarkar, D.4
Fisher, P.B.5
-
10
-
-
36849061266
-
Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity
-
10.1038/sj.onc.1210572. 17563745
-
Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. N Kikuno H Shiina S Urakami K Kawamoto H Hirata Y Tanaka RF Place D Pookot S Majid M Igawa R Dahiya, Oncogene 2007 26 7647 7655 10.1038/sj.onc.1210572 17563745
-
(2007)
Oncogene
, vol.26
, pp. 7647-7655
-
-
Kikuno, N.1
Shiina, H.2
Urakami, S.3
Kawamoto, K.4
Hirata, H.5
Tanaka, Y.6
Place, R.F.7
Pookot, D.8
Majid, S.9
Igawa, M.10
Dahiya, R.11
-
11
-
-
32944459561
-
Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: Implications for tumor progression and metastasis
-
10.1158/0008-5472.CAN-05-3029. 16452207
-
Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. L Emdad D Sarkar ZZ Su A Randolph H Boukerche K Valerie PB Fisher, Cancer Res 2006 66 1509 1516 10.1158/0008-5472.CAN-05-3029 16452207
-
(2006)
Cancer Res
, vol.66
, pp. 1509-1516
-
-
Emdad, L.1
Sarkar, D.2
Su, Z.Z.3
Randolph, A.4
Boukerche, H.5
Valerie, K.6
Fisher, P.B.7
-
12
-
-
33748458071
-
Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene
-
10.1007/s00280-006-0224-7. 16532342
-
Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. X Song X Liu W Chi Y Liu L Wei X Wang J Yu, Cancer Chemother Pharmacol 2006 58 776 784 10.1007/s00280-006-0224-7 16532342
-
(2006)
Cancer Chemother Pharmacol
, vol.58
, pp. 776-784
-
-
Song, X.1
Liu, X.2
Chi, W.3
Liu, Y.4
Wei, L.5
Wang, X.6
Yu, J.7
-
13
-
-
1842634484
-
Metadherin, a cell surface protein in breast tumors that mediates lung metastasis
-
10.1016/S1535-6108(04)00079-0. 15093543
-
Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. DM Brown E Ruoslahti, Cancer Cell 2004 5 365 374 10.1016/S1535-6108(04)00079-0 15093543
-
(2004)
Cancer Cell
, vol.5
, pp. 365-374
-
-
Brown, D.M.1
Ruoslahti, E.2
-
14
-
-
50349090038
-
Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival
-
10.1158/1078-0432.CCR-07-4054. 18519759
-
Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. J Li N Zhang LB Song WT Liao LL Jiang LY Gong J Wu J Yuan HZ Zhang MS Zeng M Li, Clin Cancer Res 2008 14 3319 3326 10.1158/1078-0432.CCR-07-4054 18519759
-
(2008)
Clin Cancer Res
, vol.14
, pp. 3319-3326
-
-
Li, J.1
Zhang, N.2
Song, L.B.3
Liao, W.T.4
Jiang, L.L.5
Gong, L.Y.6
Wu, J.7
Yuan, J.8
Zhang, H.Z.9
Zeng, M.S.10
Li, M.11
-
15
-
-
39149100913
-
Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling
-
10.1038/sj.onc.1210713. 17704808
-
Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. SG Lee ZZ Su L Emdad D Sarkar TF Franke PB Fisher, Oncogene 2008 27 1114 1121 10.1038/sj.onc.1210713 17704808
-
(2008)
Oncogene
, vol.27
, pp. 1114-1121
-
-
Lee, S.G.1
Su, Z.Z.2
Emdad, L.3
Sarkar, D.4
Franke, T.F.5
Fisher, P.B.6
|